HEADER TRANSFERASE/TRANSFERASE INHIBITOR 28-JUN-11 3SMJ TITLE HUMAN POLY(ADP-RIBOSE) POLYMERASE 14 (PARP14/ARTD8) - CATALYTIC DOMAIN TITLE 2 IN COMPLEX WITH A PYRIMIDINE-LIKE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 14; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: PARP-14, B AGGRESSIVE LYMPHOMA PROTEIN 2; COMPND 6 EC: 2.4.2.30; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BAL2, KIAA1268, PARP14; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) R3 PRARE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC-BSA4 KEYWDS DIPHTHERIA TOXIN LIKE FOLD, TRANSFERASE, NAD+, ADP-RIBOSYLATION, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX, STRUCTURAL GENOMICS, KEYWDS 3 STRUCTURAL GENOMICS CONSORTIUM, SGC EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,M.MOCHE,C.H.ARROWSMITH,H.BERGLUND,C.BOUNTRA,A.M.EDWARDS, AUTHOR 2 T.EKBLAD,S.GRASLUND,E.KOUZNETSOVA,P.NORDLUND,T.NYMAN,A.G.THORSELL, AUTHOR 3 L.TRESAUGUES,J.WEIGELT,H.SCHULER,STRUCTURAL GENOMICS CONSORTIUM AUTHOR 4 (SGC) REVDAT 4 13-SEP-23 3SMJ 1 REMARK SEQADV REVDAT 3 21-MAR-12 3SMJ 1 JRNL REVDAT 2 07-MAR-12 3SMJ 1 JRNL SOURCE REVDAT 1 20-JUL-11 3SMJ 0 JRNL AUTH E.WAHLBERG,T.KARLBERG,E.KOUZNETSOVA,N.MARKOVA,A.MACCHIARULO, JRNL AUTH 2 A.G.THORSELL,E.POL,A.FROSTELL,T.EKBLAD,D.ONCU,B.KULL, JRNL AUTH 3 G.M.ROBERTSON,R.PELLICCIARI,H.SCHULER,J.WEIGELT JRNL TITL FAMILY-WIDE CHEMICAL PROFILING AND STRUCTURAL ANALYSIS OF JRNL TITL 2 PARP AND TANKYRASE INHIBITORS. JRNL REF NAT.BIOTECHNOL. V. 30 283 2012 JRNL REFN ISSN 1087-0156 JRNL PMID 22343925 JRNL DOI 10.1038/NBT.2121 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 59602 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3137 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4283 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2330 REMARK 3 BIN FREE R VALUE SET COUNT : 225 REMARK 3 BIN FREE R VALUE : 0.2920 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3014 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.02000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : -1.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.077 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.048 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.247 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3159 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2083 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4308 ; 1.735 ; 1.932 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5045 ; 0.938 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 378 ; 6.373 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 168 ;33.322 ;24.345 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 475 ;11.566 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;20.288 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 441 ; 0.104 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3579 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 665 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1879 ; 1.112 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 747 ; 0.330 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3050 ; 1.976 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1280 ; 2.846 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1255 ; 4.477 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3SMJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1000066386. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97908 REMARK 200 MONOCHROMATOR : SI(111) MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62739 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : 0.05500 REMARK 200 FOR THE DATA SET : 17.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.39000 REMARK 200 R SYM FOR SHELL (I) : 0.26700 REMARK 200 FOR SHELL : 5.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3SMI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 0.1M BIS-TRIS, 0.2M REMARK 280 NA2SO4, PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.73650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.40150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.87750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 72.40150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.73650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.87750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1528 REMARK 465 MET A 1529 REMARK 465 ASP A 1530 REMARK 465 MET A 1531 REMARK 465 LYS A 1532 REMARK 465 SER B 1528 REMARK 465 MET B 1529 REMARK 465 ASP B 1530 REMARK 465 MET B 1531 REMARK 465 LYS B 1532 REMARK 465 GLN B 1533 REMARK 465 GLN B 1534 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B1618 CD NE CZ NH1 NH2 REMARK 470 ARG B1648 CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A1661 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG A1661 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 ASP B1694 CB - CG - OD1 ANGL. DEV. = 7.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A1535 157.68 -49.31 REMARK 500 TYR A1646 -64.74 -104.51 REMARK 500 SER A1673 -34.88 -131.95 REMARK 500 TYR B1646 -65.24 -95.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FDR A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1721 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FDR B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3GOY RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH 3AB REMARK 900 RELATED ID: 3SE2 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH 6(5H)-PHENANTHRIDINONE REMARK 900 RELATED ID: 3SMI RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH A QUINAZOLINE INHIBITOR DBREF 3SMJ A 1530 1720 UNP Q460N5 PAR14_HUMAN 1611 1801 DBREF 3SMJ B 1530 1720 UNP Q460N5 PAR14_HUMAN 1611 1801 SEQADV 3SMJ SER A 1528 UNP Q460N5 EXPRESSION TAG SEQADV 3SMJ MET A 1529 UNP Q460N5 EXPRESSION TAG SEQADV 3SMJ SER B 1528 UNP Q460N5 EXPRESSION TAG SEQADV 3SMJ MET B 1529 UNP Q460N5 EXPRESSION TAG SEQRES 1 A 193 SER MET ASP MET LYS GLN GLN ASN PHE CYS VAL VAL GLU SEQRES 2 A 193 LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SER SEQRES 3 A 193 LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU LYS SEQRES 4 A 193 ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER TYR SEQRES 5 A 193 GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY GLN SEQRES 6 A 193 THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP ALA SEQRES 7 A 193 GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN ARG SEQRES 8 A 193 SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS GLY SEQRES 9 A 193 THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN ASP SEQRES 10 A 193 THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS VAL SEQRES 11 A 193 TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS GLY SEQRES 12 A 193 ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO GLN SEQRES 13 A 193 ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN VAL SEQRES 14 A 193 HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR GLN SEQRES 15 A 193 ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS SEQRES 1 B 193 SER MET ASP MET LYS GLN GLN ASN PHE CYS VAL VAL GLU SEQRES 2 B 193 LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SER SEQRES 3 B 193 LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU LYS SEQRES 4 B 193 ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER TYR SEQRES 5 B 193 GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY GLN SEQRES 6 B 193 THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP ALA SEQRES 7 B 193 GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN ARG SEQRES 8 B 193 SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS GLY SEQRES 9 B 193 THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN ASP SEQRES 10 B 193 THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS VAL SEQRES 11 B 193 TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS GLY SEQRES 12 B 193 ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO GLN SEQRES 13 B 193 ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN VAL SEQRES 14 B 193 HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR GLN SEQRES 15 B 193 ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS HET FDR A 1 14 HET GOL A1721 6 HET FDR B 2 14 HETNAM FDR 2-METHYL-3,5,6,7-TETRAHYDRO-4H-CYCLOPENTA[4,5]THIENO[2, HETNAM 2 FDR 3-D]PYRIMIDIN-4-ONE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 FDR 2(C10 H10 N2 O S) FORMUL 4 GOL C3 H8 O3 FORMUL 6 HOH *290(H2 O) HELIX 1 1 GLU A 1547 SER A 1560 1 14 HELIX 2 2 ASN A 1572 ASN A 1590 1 19 HELIX 3 3 ASP A 1604 GLY A 1606 5 3 HELIX 4 4 SER A 1607 GLY A 1615 1 9 HELIX 5 5 GLY A 1622 VAL A 1626 5 5 HELIX 6 6 ASN A 1637 ALA A 1642 1 6 HELIX 7 7 ASP B 1545 SER B 1560 1 16 HELIX 8 8 ASN B 1572 ASN B 1590 1 19 HELIX 9 9 ASP B 1604 GLY B 1606 5 3 HELIX 10 10 SER B 1607 GLY B 1615 1 9 HELIX 11 11 ASN B 1637 ALA B 1642 1 6 HELIX 12 12 TYR B 1706 TYR B 1708 5 3 SHEET 1 A10 GLU A1596 THR A1603 0 SHEET 2 A10 LYS A1655 LEU A1663 -1 O VAL A1660 N LEU A1599 SHEET 3 A10 ALA A1710 ARG A1719 -1 O PHE A1718 N LYS A1655 SHEET 4 A10 ARG A1563 GLN A1571 -1 N LYS A1566 O THR A1717 SHEET 5 A10 PHE A1536 GLU A1540 -1 N CYS A1537 O GLN A1571 SHEET 6 A10 PHE B1536 GLU B1540 -1 O PHE B1536 N VAL A1538 SHEET 7 A10 ARG B1563 GLN B1571 -1 O GLN B1571 N CYS B1537 SHEET 8 A10 ALA B1710 ARG B1719 -1 O ARG B1719 N ARG B1563 SHEET 9 A10 LYS B1655 LEU B1663 -1 N LYS B1655 O PHE B1718 SHEET 10 A10 GLU B1596 THR B1603 -1 N LEU B1599 O VAL B1660 SHEET 1 B 4 THR A1632 ALA A1635 0 SHEET 2 B 4 LEU A1701 ALA A1704 -1 O ALA A1704 N THR A1632 SHEET 3 B 4 THR A1691 THR A1693 -1 N VAL A1692 O VAL A1703 SHEET 4 B 4 TYR A1667 HIS A1669 1 N THR A1668 O THR A1693 SHEET 1 C 4 THR B1632 ALA B1635 0 SHEET 2 C 4 LEU B1701 ALA B1704 -1 O PHE B1702 N PHE B1634 SHEET 3 C 4 THR B1691 THR B1693 -1 N VAL B1692 O VAL B1703 SHEET 4 C 4 TYR B1667 HIS B1669 1 N THR B1668 O THR B1693 SSBOND 1 CYS A 1537 CYS B 1537 1555 1555 2.10 SITE 1 AC1 10 HOH A 289 HIS A1601 GLY A1602 TYR A1633 SITE 2 AC1 10 ALA A1635 TYR A1640 SER A1641 TYR A1646 SITE 3 AC1 10 PRO A1682 GLN A1683 SITE 1 AC2 6 HOH A 2 HOH A 65 HOH A 264 HIS A1601 SITE 2 AC2 6 THR A1603 ARG A1618 SITE 1 AC3 7 HOH B 88 HIS B1601 GLY B1602 GLY B1622 SITE 2 AC3 7 TYR B1633 SER B1641 TYR B1646 CRYST1 39.473 67.755 144.803 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025334 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014759 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006906 0.00000